Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema

with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and...